Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Feasibility Study to Assess the Safety and Functionality of the GluSense Continuous Glucose Monitor in Diabetic Patients

This study has been completed.
Sponsor:
Information provided by:
GluSense Ltd
ClinicalTrials.gov Identifier:
NCT01198678
First received: September 8, 2010
Last updated: March 29, 2011
Last verified: December 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2011
  Primary Completion Date: January 2011 (Final data collection date for primary outcome measure)